Biotech stock NovaBay jumps 19% amid pivot, rebrand to Stablecoin Development Corporation
In a surprising turn of events, NovaBay Pharmaceuticals has rebranded itself as the Stablecoin Development Corporation, marking a significant pivot from its traditional biotech roots to embrace the burgeoning world of cryptocurrency. This strategic shift has already paid dividends, with the company’s stock surging by an impressive 19% following the announcement. The rebranding reflects a … Read more